CD177 and neoplasm: Accumulating evidence has confirmed that CD36, a cell surface receptor of FAs, allows cells to take up lipids from the extracellular microenvironment and promotes FA oxidation (FAO) to produce ATP [9–12] potentially energizing tumor progression and metastasis [13–16].